Related Experiment Video
Updated: Mar 10, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Functional selectivity of cannabinoids at CB1 receptors: Comprehensive analysis of G proteins, β-arrestin and cAMP
Noor AlAli1, Benjamin J Wheaton1, Stig O P Jacobsson1
1Department of Medical and Translational Biology, Umeå University, SE-901 87, Umeå, Sweden.
Abstract:
Therapeutic targeting of CB1 has been limited by adverse effects of orthosteric ligands. Allosteric modulation and biased signalling have been proposed to achieve pathway-selective control, but the receptor's complex coupling complicates interpretation of ligand actions. In this study, we systematically compared orthosteric and allosteric CB1 ligands in transfected HEK293T cells by measuring G-protein coupling and downstream cAMP regulation in real time using NanoBiT and GloSensor assays. Orthosteric agonists CP 55,940 and methanandamide activated both Gi and Gs with weak and transient β-arrestin2 recruitment, producing potent inhibition of forskolin-stimulated cAMP and modest increases in basal levels. The inverse agonist AM251 reduced basal Gi coupling and increased basal cAMP, consistent with inverse agonism at constitutively active CB1 receptors. Under forskolin stimulation, AM251 attenuated agonist-induced inhibition of cAMP and produced concentration-dependent modulation of forskolin-stimulated responses. AM4113 marginally reduced G-protein coupling and increased basal, while modestly reducing forskolin-stimulated cAMP, consistent with very low inverse efficacy. Among allosteric ligands, the positive allosteric modulator GAT229 increased Gi coupling and, with orthosteric agonists, further enhanced Gi and Gs signalling, elevating basal cAMP, without affecting β-arrestin2. The negative allosteric modulators PSNCBAM-1 and ORG27569 each reduced Gi- and Gs-coupling, elevated basal cAMP, and attenuated agonist-induced inhibition of forskolin-stimulated cAMP. Cannabidiol showed no intrinsic activity at CB1 and marginally reduced orthosteric G-protein signalling, consistent with indirect interaction with the receptor. In summary, this study shows that orthosteric and allosteric CB1 ligands differ in G-protein coupling and cAMP regulation, clarifying key aspects of cannabinoid receptor signalling.
Related Concept Videos
Dose-Response Relationship: Selectivity and Specificity
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Opioid Receptors: Overview
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drug-Receptor Bonds
In...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...

